Overview
A thioxanthine used as an antipsychotic agent. Its effects are similar to the phenothiazine antipsychotics.
Indication
For the management of schizophrenia.
Associated Conditions
- Schizophrenia
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2015/11/09 | N/A | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Carilion Materials Management | 68151-2486 | ORAL | 5 mg in 1 1 | 1/14/2010 | |
| Amneal Pharmaceuticals NY LLC | 60219-1673 | ORAL | 1 mg in 1 1 | 12/28/2023 | |
| Golden State Medical Supply, Inc. | 51407-278 | ORAL | 10 mg in 1 1 | 8/24/2023 | |
| State of Florida DOH Central Pharmacy | 53808-0817 | ORAL | 10 mg in 1 1 | 9/30/2013 | |
| Golden State Medical Supply, Inc. | 51407-276 | ORAL | 2 mg in 1 1 | 8/24/2023 | |
| Novitium Pharma LLC | 70954-014 | ORAL | 1 mg in 1 1 | 9/10/2020 | |
| Golden State Medical Supply, Inc. | 51407-277 | ORAL | 5 mg in 1 1 | 8/24/2023 | |
| Amneal Pharmaceuticals NY LLC | 60219-1674 | ORAL | 2 mg in 1 1 | 12/28/2023 | |
| Amneal Pharmaceuticals NY LLC | 60219-1675 | ORAL | 5 mg in 1 1 | 12/28/2023 | |
| DOH CENTRAL PHARMACY | 53808-1129 | ORAL | 2 mg in 1 1 | 1/28/2019 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| NAVANE CAPSULES 10MG | erfa canada 2012 inc | 00024457 | Capsule - Oral | 10 MG | 12/31/1969 |
| NAVANE | searchlight pharma inc | 00024449 | Capsule - Oral | 5 MG | 12/31/1969 |
| NAVANE CAP 2MG | erfa canada 2012 inc | 00024430 | Capsule - Oral | 2 MG | 12/31/1969 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.